Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Effects of Abemaciclib and Endocrine Therapy in Advanced Breast Cancer
NCT04352777Phase 2Completed
- Sponsor
- Duke University
- Start
- Sep 2020
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in breast cancer, sponsored by Duke University. Started Sep 2020; status: completed.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04352777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04352777.